Woman’s Hospital has been awarded full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its dedication to improving the health of patients and the community through research.
Research at Woman’s helps providers learn new ways to promote healthy living, improve health during pregnancy, and prevent and treat illnesses. A few recent studies include:
SWEET Study: Women who have had gestational diabetes during pregnancy are 10 times more likely to develop Type 2 diabetes in the future. This study will help researchers learn if a once-a-week, FDA-approved medication called semaglutide (Ozempic®) can help postpartum women who have been diagnosed with gestational diabetes in the past have healthy blood sugar levels and fight pre-diabetes.
Pandemic Pregnancy Study: Using results collected through a comprehensive survey, researchers are learning how pregnant women in Louisiana felt during the COVID-19 pandemic and how the pandemic affected pregnancy outcomes for moms and babies. Woman’s is conducting this study in partnership with Pennington Biomedical Research Center and Tulane University.
Miracle of Life Study: This study aims to find a blood test that can predict pregnancy complications, like having your baby too early, preeclampsia, and gestational diabetes. Researchers study the blood drawn from participating pregnant patients to try to find any links that would signal future complications. Finding an early link could result in preventative treatments for pregnant patients.
AAHRPP promotes high-quality, ethically sound research through an accreditation process that helps organizations worldwide strengthen their human research protection programs. To earn accreditation, organizations must provide tangible evidence-through policies, procedures, and practices—of their commitment to scientifically and ethically sound research and to continuous improvement.
AAHRPP has accredited research entities across the U.S. and in Australia, Belgium, Brazil, Canada, China, India, Jordan, Mexico, Republic of Korea, Saudi Arabia, Singapore, Taiwan, and Thailand.